Mark your calendars for Tuesday 29th October 2024, as BioMarin Pharmaceutical (NASDAQ: BMRN) is set to unveil its third quarter financial results. This highly anticipated announcement will be made after market close, giving investors and market participants a chance to assess the company's financial performance.
It is anticipated by financial experts on Wall Street that the business is set to announce an estimated $0.52 profit per share for the quarter. Additionally, the firm is expected to disclose a total revenue of $700.14 million for this period.
The projections from Wall Street analysts indicate that the company is expected to generate a total revenue of $2.8 billion for the full year. Moreover, they anticipate the earnings per share to reach profit of $2.07 during the fiscal year.
The company's earnings report for the same quarter in the previous year revealed a per-share income of $0.46, attributed to the company's total revenue of $581.33 million.
[stock_market_widget type=”chart” template=”line2″ assets=BMRN range=”1y” interval=”1wk” price_field=”close” heading=”{symbol}” line_width=”2″ gradient_direction=”bottom” gradient_size=”1″ line_color=”#1b6dc1″ area_background_color=”#1b6dc1″ area_background_color2=”#ffffff” axes_color=”#000000″ tooltip_text_color=”#262626″ tooltip_background_color=”#ffffff” range_selector=”false” volume_enabled=”false” axes_enabled=”true” tooltip_enabled=”false” events_enabled=”false” smoothing_enabled=”true” zoom_enabled=”false” save_image_enabled=”false” api=”yahoo-finance”]
BMRN will host a conference call with investment community on 29th October 2024 at 04:30 PM eastern time to discuss the financial results.
Throughout Friday's trading, BioMarin Pharmaceutical (BMRN) shares fluctuated between $69.66 and $70.98, with a trading volume of 1.06 million shares. The stock ended the regular trading session at $69.73, reflecting drop of 0.94 percent.
